RegeneRx Announces First Patients Enrolled in Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) with RGN-259
Date
2016-11-09
RegeneRx Announces First Patients Enrolled in Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) with RGN-259
(if you want to view the body of article, click on the bottom link)
http://www.prnewswire.com/news-releases/regenerx-announces-first-patients-enrolled-in-phase-3-us-dry-eye-clinical-trial-arise-2-trial-with-rgn-259-300359779.html
(if you want to view the body of article, click on the bottom link)
http://www.prnewswire.com/news-releases/regenerx-announces-first-patients-enrolled-in-phase-3-us-dry-eye-clinical-trial-arise-2-trial-with-rgn-259-300359779.html